NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
Sloan's Lake Dental, led by Dr. Sage Pollack and a team of multidisciplinary experts, celebrates a major milestone of over 600 5-star reviews on Google Maps.
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions, Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
Private autopsy services are becoming an increasingly sought-after service for Colorado families who want a thorough investigation of their loved one's death.
Har Dental Group announces opening two new state-of-the-art locations in Plainview and Slaton, Texas, enhancing access to advanced dental care and innovative treatment solutions in the region. Led by Dr.
CelluHeal™, a trusted provider of advanced wound care supplies, is pleased to announce the nationwide and international availability of its full selection of professional wound dressings, including the flagship Cellufil® and Cellusheet™ collagen...
Nonprofit dedicated to improving congenital heart defect treatment and education is honored to receive message of support from Brian Littrell of the Backstreet Boys
West Dentistry in Jacksonville, FL, is thrilled to announce the addition of a highly skilled oral surgeon to their team, further expanding their comprehensive dental services.
VSee Health (N A S D A Q: VSEE) $VSEE Major Clients Include NASA, U.S. Department of Health and Human Services, McKesson, DaVita and the Entire Nation of Qatar
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
869 views, By Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) has officially accepted its New Drug Application (NDA) for Azstarys (serdexmethylphenidate/dexmethylphenidate extended-release...
ReproTech LLC ("ReproTech") has made a significant growth investment in Matcher Technologies Ltd ("Matcher") to support its expansion across the fertility sector.
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
Sloan's Lake Dental, led by Dr. Sage Pollack and a team of multidisciplinary experts, celebrates a major milestone of over 600 5-star reviews on Google Maps.
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions, Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
Ameco Research's Plasmid DNA Manufacturing Market Report shows market size of USD 2.13 Billion in 2024 expanding to USD 10.67 Billion by 2033 at 19.8% CAGR. Gain insights into market share, growth drivers, and regional trends.
Private autopsy services are becoming an increasingly sought-after service for Colorado families who want a thorough investigation of their loved one's death.
Har Dental Group announces opening two new state-of-the-art locations in Plainview and Slaton, Texas, enhancing access to advanced dental care and innovative treatment solutions in the region. Led by Dr.
Red biotechnology market is projected to hit USD 656.1 billion by 2032, fuelled by genomics, biologic therapies, and rising demand for personalized medicine.
The global Cryogenic Tanks Market size is projected to reach USD 12.03 Billion by 2033, growing at a CAGR of 5.6%. Explore market size, share, growth, and trends by Ameco Research.
CelluHeal™, a trusted provider of advanced wound care supplies, is pleased to announce the nationwide and international availability of its full selection of professional wound dressings, including the flagship Cellufil® and Cellusheet™ collagen...
The global karyotyping market is projected to reach USD 535.3 million by 2032, driven by growing adoption in prenatal screening, cancer diagnostics, and personalized medicine.
The global gene editing market size was valued at USD 6 billion in 2024 and is likely to reach USD 22 billion by 2033, expanding at a CAGR 15.6% during the forecast period.
Nonprofit dedicated to improving congenital heart defect treatment and education is honored to receive message of support from Brian Littrell of the Backstreet Boys
West Dentistry in Jacksonville, FL, is thrilled to announce the addition of a highly skilled oral surgeon to their team, further expanding their comprehensive dental services.
St. Helens, Oregon – Control Solutions Inc. has been awarded a national group purchasing agreement for Biomedical Refrigeration and Freezers with Premier, Inc.
VSee Health (N A S D A Q: VSEE) $VSEE Major Clients Include NASA, U.S. Department of Health and Human Services, McKesson, DaVita and the Entire Nation of Qatar
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032
The global chimeric antigen receptor (CAR) T-cell therapy market size was valued at USD 4.6 billion in 2024 and is projected to hit around USD 18.1 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025 to 2033.
869 views, By Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) has officially accepted its New Drug Application (NDA) for Azstarys (serdexmethylphenidate/dexmethylphenidate extended-release...
